Diagnosing Invasive Candidiasis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Cultures are negative in ∼50% of invasive candidiasis. Data are emerging for the performance of nonculture tests such as mannan/antimannan, Candida albicans germ tube antibody, 1,3-β- d -glucan, PCR, and the T2Candida panel in diagnosing both candidemia and deep-seated candidiasis. In most settings, positive predictive values of nonculture test are low, and negative predictive values are high. For tests to be useful, clinicians must understand the pretest likelihood of invasive candidiasis and test performance for the most common disease manifestation in a given patient. This paper reviews nonculture Candida diagnostics and discusses how they might be used effectively in patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One limitation is that we may be missing sterile site infections as well as candidemic patients with deep-seated infections due to limitations with current detection methods [28].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“with the sensitivity of blood culture around or less than 50% [28].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [28]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other studies, however, did not observe an association between antimicrobial timing and mortality (112-117).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [115]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793 · cited 1×
“Timely antifungal therapy and source control are crucial determinants of survival in patients with invasive candidiasis (1, 2).”
BackgroundClancy, C. J., & Nguyen, M. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit006 · Cited by 688 · cited 5×
“Cultures of material collected from deep sites of infection are also only 50% sensitive, likely reflecting small sample volumes and uneven distribution and low burdens of Candida cells (3).”
BackgroundInfluentialSelf-citation-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538 · cited 1×
“65% to 85% and 75% to 85%, respectively) (12, 13).”
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Mylonakis, E., Clancy, C. J., Ostrosky-Zeichner, L., Garey, K. W., Alangaden, G. J., Vazquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu959 · Cited by 443 · cited 10×
“FDA clearance of T2Candida was based on data from the multicenter DIRECT trial, which included 1,500 control patients with Candida-negative blood cultures, 6 patients with Candida-positive blood cultures, and 250 contrived blood specimens spiked with C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, or C. krus…”
InfluentialSelf-citationPCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389 · cited 1×
“and 92% (95% CI, 87 to 98%), respectively (17).”
Onishi, A., Sugiyama, D., Kogata, Y., Saegusa, J., Sugimoto, T., Kawano, S., Morinobu, A., Nishimura, K., & Kumagai, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05267-11 · Cited by 328 · cited 1×
“65% to 85% and 75% to 85%, respectively) (12, 13).”
Mikulska, M., Calandra, T., Sanguinetti, M., Poulain, D., Viscoli, C., & the Third European Conference on Infections in Leukemia Group (2010) · Critical Care · doi:10.1186/cc9365 · Cited by 319 · cited 1×
“In a meta-analysis of 14 studies, the sensitivities and specificities of mannan and antimannan for invasive candidiasis were 58% and 93%, and 59% and 86%, respectively (7).”
BackgroundNguyen, M. H., Wissel, M. C., Shields, R. K., Salomoni, M. A., Hao, B., Press, E. G., Shields, R. M., Cheng, S., Mitsani, D., Vadnerkar, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis200 · Cited by 290 · cited 2×
“The sensitivity and specificity of PCR are estimated from the studies of deep-seated candidiasis cited in the text and in Table 1 (9, 10, 22).”
BackgroundSelf-citationPfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274 · cited 6×
“FDA clearance of T2Candida was based on data from the multicenter DIRECT trial, which included 1,500 control patients with Candida-negative blood cultures, 6 patients with Candida-positive blood cultures, and 250 contrived blood specimens spiked with C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, or C. krus…”
BackgroundInfluentialLaboratory diagnosis of invasive candidiasis.
Ellepola, A. N. B., & Morrison, C. J. (2005) · PubMed · Cited by 260
CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS
Calandra, T., Schneider, R., Bille, J., Mosimann, F., & Francioli, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92043-6 · Cited by 239 · cited 1×
“30 (23, 25) Patient who has undergone high-risk GI/hepatobiliary surgery, patient with a biliary leak, patient with a gastric/ duodenal perforation 53 83 35 83.”
Backgroundβ-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis
Tissot, F., Lamoth, F., Hauser, P. M., Orasch, C., Flückiger, U., Siegemund, M., Zimmerli, S., Calandra, T., Bille, J., Eggimann, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2069oc · Cited by 203 · cited 2×
“, 2013 (23) IAC or urologic candidiasis (11) vs at-risk ICU pts and healthy controls (76) 64 83 Fortun et al.”
BackgroundClancy, C. J., Pappas, P. G., Vazquez, J., Judson, M. A., Kontoyiannis, D. P., Thompson, G. R., Garey, K. W., Reboli, A., Greenberg, R. N., Apewokin, S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1095 · Cited by 165
Self-citationQuantitation of Candida CFU in Initial Positive Blood Cultures
Pfeiffer, C. D., Samsa, G. P., Schell, W. A., Reller, L. B., Perfect, J. R., & Alexander, B. D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00609-11 · Cited by 158 · cited 4×
“At the time of the first positive blood culture, the median Candida concentration is 1 CFU/ml (4).”
BackgroundInfluentialUpdate on Fungal Peritonitis and its Treatment
Matuszkiewicz–Rowinska, J. (2009) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.1177/089686080902902s31 · Cited by 153 · cited 1×
“5 (26, 28) Low- to moderate-risk peritoneal dialysis patient with peritonitis 12 97.”
BackgroundIntra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
Vergidis, P., Clancy, C. J., Shields, R. K., Park, S. Y., Wildfeuer, B. N., Simmons, R. L., & Nguyen, M. H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153247 · Cited by 150 · cited 1×
“Timely antifungal therapy and source control are crucial determinants of survival in patients with invasive candidiasis (1, 2).”
BackgroundSelf-citationHanson, K. E., Pfeiffer, C. D., Lease, E. D., Balch, A. H., Zaas, A. K., Perfect, J. R., & Alexander, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042282 · Cited by 122
Alexander, B. D., Smith, P. B., Davis, R. D., Perfect, J. R., & Reller, L. B. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01183-10 · Cited by 116 · cited 1×
“results may be particularly common (15).”
The Cava Trem Study Group, León, C., Ruiz-Santana, S., Saavedra, P., Castro, C., Loza, A., Zakariya, I., Úbeda, A., Parra, M., Macías, D., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1324-3 · Cited by 110
Knitsch, W., Vincent, J.-L., Utzolino, S., François, B., Dinya, T., Dimopoulos, G., Özgüneş, İ., Valía, J. C., Eggimann, P., León, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ707 · Cited by 100
Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA
Jung, D. S., Farmakiotis, D., Jiang, Y., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2111.150404 · Cited by 97 · cited 1×
“differ by center, clinicians and labs must be aware of local data (19).”
BackgroundFortun, J., Meije, Y., Buitrago, M. J., Gago, S., Bernal-Martinez, L., Peman, J., Perez, M., Gomez-G Pedrosa, E., Madrid, N., Pintado, V., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku225 · Cited by 61 · cited 1×
“The sensitivity and specificity of PCR are estimated from the studies of deep-seated candidiasis cited in the text and in Table 1 (9, 10, 22).”
BackgroundPotential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia
Martínez‐Jiménez, M. D. C., Muñóz, P., Guinea, J., Valerio, M., Alonso, R., Escribano, P., & Bouza, E. (2014) · Medical Mycology · doi:10.1093/mmy/myt025 · Cited by 56 · cited 2×
“Data are less extensive for CAGTA, which detects responses against a hyphal protein (Hwp1) expressed during tissue invasion and biofilm formation (8).”
BackgroundEricson, E.-L., Klingspor, L., Ullberg, M., & Özenci, V. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.02.020 · Cited by 55 · cited 1×
“Fungal selective media can improve blood culture sensitivity and shorten the time to positivity (5).”
BackgroundPrediction of invasive candidal infection in critically ill patients with severeacute pancreatitis
Hall, A., Poole, L., Renton, B., Wozniak, A., Fisher, M., Neal, T. J., Halloran, C. M., Cox, T. F., & Hampshire, P. A. (2013) · Critical Care · doi:10.1186/cc12569 · Cited by 44 · cited 2×
“20 (26, 27) Patient with high-risk severe acute or necrotizing pancreatitis, patient with small-bowel perforation, patient with emergent surgery for nosocomial intra-abdominal infection 39 89.”
Backgroundthe CAVA Trem Study Group, Parra-Sánchez, M., Breval, I. Z.-Y., Méndez, C. C., García-Rey, S., Vázquez, A. L., Úbeda, A., Guerrero, D. M., Mejías, A. R., Gil, C. L., et al. (2017) · Mycopathologia · doi:10.1007/s11046-017-0125-9 · Cited by 33
Current Laboratory Approaches to Diagnosis of CNS Fungal Infections
Lyons, J. L., & Zhang, S. X. (2016) · Future Microbiology · doi:10.2217/fmb.15.138 · Cited by 16 · cited 1×
“and other sample types report promising results (16).”
BackgroundClancy, C. J., Shields, R. K., & Nguyen, M. H. (2016) · Journal of Fungi · doi:10.3390/jof2010010 · Cited by 13 · cited 2×
“, 2012 (22) IAC (29) vs at-risk ICU pts (60) 65e 78 Tissot et al.”
BackgroundSelf-citationDiagnostic Methods for Detection of Blood-Borne Candidiasis
Clancy, C. J., & Nguyen, M. H. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3052-4_16 · Cited by 13 · cited 2×
“Indeed, nonculture tests are Bayesian biomarkers that assign a probability of infection, rather than definitive diagnostics (24).”
BackgroundSelf-citationWhen Diagnostic Technology Is Ahead of the Hospital Budget: What Is Antimicrobial Stewardship to Do?
Bauer, K. A. A., & Goff, D. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ355 · Cited by 5 · cited 1×
“” Given the importance of clinical context in interpreting results and the complexity of subsequent therapeutic decisions, centers may benefit from the expertise of diagnostic stewardship teams (30).”
Background
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Donnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,917
“This includes patients with hematologic malignancies with and without neutropenia, neutropenia following HSCT, and certain patients in the ICU who are at higher risk (>10%) for IC as a result of gastrointestinal surgery with recurrent anastomotic leaks, perforations of the upper gastrointestinal tract, or necrotizing…”
BackgroundSelf-citationSong, G., Liang, G., & Liu, W. (2020) · Mycopathologia · doi:10.1007/s11046-020-00462-9 · Cited by 644
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438
“Early detection is especially important in patients at high risk for developing invasive fungal diseases; examples of existing strategies include galactomannan assay for aspergillosis and β-D-glucan and T2Candida for invasive candidiasis [34].”
Background
Metadata
- Authors
- Clancy, C. J., & Nguyen, M. H.
- Affiliations
- University of Pittsburgh (US)
- VA Pittsburgh Healthcare System (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2018-05
- Volume
- 56
- Issue
- 5
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5925725
- OpenAlex
- W2790020787
- Cited by
- 293
- References
- 30
- Citations by year
- 2026: 30 · 2025: 38 · 2024: 34 · 2023: 46 · 2022: 38 · 2021: 45 · 2020: 33 · 2019: 21 · 2018: 8
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- invasive candidiasis, candidemia, germ tube test, β-1,3-glucan, PCR, diagnostic performance, positive predictive value, negative predictive value, pretest probability
- MeSH terms
- Clinical Decision-Making, Antibodies, Fungal, Antigens, Fungal, Candida, DNA, Fungal, Sensitivity and Specificity, Clinical Laboratory Techniques, Candidiasis, Invasive, Intraabdominal Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.